Hypermarcas (OTCMKTS:HYPMY – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling 50,686 shares, a growth of 9,217.3% from the January 15th total of 544 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 27,516 shares, the days-to-cover ratio is presently 1.8 days. Based on an average daily trading volume, of 27,516 shares, the days-to-cover ratio is presently 1.8 days. Currently, 0.0% of the company’s stock are short sold.
Hypermarcas Stock Up 0.7%
Shares of OTCMKTS:HYPMY traded up $0.03 on Tuesday, hitting $4.46. 51,649 shares of the company traded hands, compared to its average volume of 21,276. Hypermarcas has a 52 week low of $3.10 and a 52 week high of $5.50. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The stock has a 50 day simple moving average of $4.51 and a 200-day simple moving average of $4.43. The company has a market cap of $2.82 billion, a PE ratio of 19.39 and a beta of 0.71.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last announced its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. The company had revenue of $408.83 million for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%.
Hypermarcas Company Profile
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Recommended Stories
- Five stocks we like better than Hypermarcas
- They’ve Built Major Gold Stories Before – And They’re Doing It Again
- Buy this Gold Stock Before May 2026
- Nvidia CEO Issues Bold Tesla Call
- Think You Missed Silver? You’re Wrong. Here’s Why.
- How to collect $500-$800 weekly (BlackRock’s system)
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
